2 Top Artificial Intelligence Stocks to Buy While They're on Sale

Posted Apr 27 by Two Blokes

There's a lot of uncertainty for the economy, but sticking with top artificial intelligence (AI) companies sti

Source: Two Blokes Trading

Does Wall Street's Sell-Off Have You Interested in Gold? 2 ETFs You'll Want to Dig Into.

Posted Apr 27 by Two Blokes

The S&P 500 (^GSPC 0.74%) is down over 10% from highs set earlier this year. The Nasdaq Composite (^IXIC 1.26%

Source: Two Blokes Trading

Profit From Wider Credit Spreads With These High-Yield Bond Funds

Posted Apr 27 by Two Blokes

The ongoing trade war has led to a massive increase in uncertainty and bearish sentiment. Credit spreads have

Source: Two Blokes Trading

Buy the Dip: Which S&P 500 Index ETF Is the Best Choice Right Now?

Posted Apr 27 by Two Blokes

The S&P 500 index (^GSPC 0.74%) has dipped more than 10% from its peak in 2025. That puts the market gauge int

Source: Two Blokes Trading

Resistance Shattered : XRP Reclaims Lost Ground

Posted Apr 27 by Two Blokes

In a constantly bustling crypto market, XRP has stood out with a rare significant movement. In just a few hour

Source: Two Blokes Trading

Should You Buy the Highest-Yielding Dow Stock After the Market Sell-Off?

Posted Apr 27 by Two Blokes

The markets have gotten turbulent, with the Dow Jones Industrial Average (^DJI 0.05%) off by a touch more than

Source: Two Blokes Trading

China has exempted some U.S. imports that the country would struggle to immediately source from elsewhere from its retaliatory t

Posted Apr 27 by Two Blokes

Beijing has been canvassing companies and waiving duties on American goods in sectors where it lacks alternati

Source: Two Blokes Trading

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Re

Posted Apr 27 by Two Blokes

NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical com

Source: Two Blokes Trading

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimo

Posted Apr 27 by Two Blokes

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohor

Source: Two Blokes Trading

UroGen Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102, an Investigati

Posted Apr 27 by Two Blokes

PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing

Source: Two Blokes Trading

New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt\u2122 PFA System for Patients with AFib

Posted Apr 27 by Two Blokes

Long-term data from the Volt CE Mark Study show strong results out to 12 months in patients receiving pulsed f

Source: Two Blokes Trading

Medtronic Affera\u2122 pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation pat

Posted Apr 27 by Two Blokes

One-year clinical trial data for the next-generation, investigational, Sphere-360\u2122 single-shot PFA cathet

Source: Two Blokes Trading